Compounds > docetaxel anhydrous
Page last updated: 2024-09-04

docetaxel anhydrous and hypericum

docetaxel anhydrous has been researched along with hypericum in 4 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)		Trials
(docetaxel anhydrous)		Recent Studies (post-2010)
(docetaxel anhydrous)		Studies
(hypericum)		Trials
(hypericum)		Recent Studies (post-2010) (hypericum)
12,1103,2166,9202,444213948

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Egorin, MJ; Komoroski, BJ; Parise, RA; Strom, SC; Venkataramanan, R1
Branda, RF; Brooks, EM; McCormack, JJ; Naud, SJ; Powden, C; Yildirim, Z1
Beijnen, JH; Burgers, JA; Goey, AK; Keessen, M; Marchetti, S; Meijerman, I; Mergui-Roelvink, M; Rosing, H; Schellens, JH1
Adeberg, S; Debus, J; Eichkorn, T; Herfarth, K; Hörner-Rieber, J; König, L; Regnery, S; Schunn, F; Shafie, RE1

Trials

1 trial(s) available for docetaxel anhydrous and hypericum

ArticleYear
The effect of St John's wort on the pharmacokinetics of docetaxel.
    Clinical pharmacokinetics, 2014, Volume: 53, Issue:1

    Topics: Adult; Aged; Antidepressive Agents; Antineoplastic Agents; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Docetaxel; Female; Herb-Drug Interactions; Humans; Hypericum; Male; Middle Aged; Plant Extracts; Taxoids

2014

Other Studies

3 other study(ies) available for docetaxel anhydrous and hypericum

ArticleYear
Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Oct-01, Volume: 11, Issue:19 Pt 1

    Topics: Aged; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Bridged Bicyclo Compounds; Chromatography, Liquid; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Docetaxel; Drug Synergism; Female; Hepatocytes; Humans; Hypericum; Ions; Liver; Mass Spectrometry; Middle Aged; Models, Chemical; Phloroglucinol; Rifampin; Taxoids; Terpenes; Time Factors

2005
Vitamin E but not St. John's wort mitigates leukopenia caused by cancer chemotherapy in rats.
    Translational research : the journal of laboratory and clinical medicine, 2006, Volume: 148, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diet; DNA Damage; DNA, Mitochondrial; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Female; Hypericum; Leukocyte Count; Leukopenia; Phytotherapy; Plant Preparations; Rats; Rats, Inbred F344; Taxoids; Vitamin E

2006
Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John's wort skin oil.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2021, Volume: 197, Issue:7

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Humans; Hypericum; Lung Neoplasms; Middle Aged; Phytochemicals; Ramucirumab

2021